A culture medium is essential for sustaining in-vitro-produced embryos longer than maturation or fertilization media (
1). Therefore, accurately defining the substrate requirements for each developmental stage is crucial for optimizing the efficacy of embryo culture media (
2). The culture medium comprises three main components: Serum, additive supplements, and growth factors. Serum is necessary in cell culture to enrich the medium, with fetal bovine serum (FBS) being the most commonly used in laboratories (
3). Historically, FBS has been extensively used in vitro culture (IVC) media due to its inclusion of embryotrophic factors (
4). Serum proteins serve multiple functions, including maintaining acid-base balance, osmotic pressure, pH stability, and providing amino acids (
5). Fetal bovine serum contains essential components crucial for cell attachment, proliferation, and maintenance, such as serum albumin, fetuin, hormones, vitamins, trace elements, and growth factors, encompassing approximately 1800 proteins and over 4000 metabolites (
6).
Despite these benefits, the precise effects of serum remain inconclusive (
5). There are several drawbacks associated with FBS use, including its undefined composition and potential adverse effects (
7). Notably, aberrant impacts on fetal growth, such as large offspring syndrome observed in cattle and sheep, have been linked to FBS supplementation in pre-implantation culture media (
8). In contrast, chemically defined media offer precisely described components and concentrations (
6), contributing to successful bovine zygote development to blastocysts (
9). While defined media supplements are commercially available for certain cell types, their formulations often lack detailed disclosure (
4).
Substituting FBS in cell culture media remains a significant challenge in cell and tissue culture (
10). Current alternatives to FBS include components derived from human blood, such as plasma, serum, umbilical cord serum, and platelet derivatives like platelet lysate (PL) (
11). Platelet lysate is derived from outdated human donor thrombocyte concentrates (
12) and upon activation releases over 300 substances from intracellular granules (
7), including adhesive proteins, coagulation factors, mitogens, protease inhibitors, proteoglycans (
13), and a wide array of growth factors. Key mitogens found in PL include platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin-like growth factor (IGF), transforming growth factor (TGF), and fibroblast growth factor 2 (FGF2), all exerting potent mitogenic effects. Additionally, PL contains cytokines and chemokines like interleukin (IL)-1β, IL-2, IL-6, IL-10, IL-12p70, IL-17A, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ (
14). Platelet-derived growth factors, for instance, promote tissue repair mechanisms such as extracellular matrix remodeling, chemotaxis, cell proliferation, and differentiation (
15).
Several culture media have been successful in supporting in vitro ovine zygote development to blastocysts, including Hams-F10, TCM199, Hams-F12, modified Brackets medium, synthetic oviductal fluid (SOF), Tyrodes medium, and various commercial media formulations. Charles Rosenkrans medium (CR1), for example, has been successfully used for bovine embryo culture (
16). Platelet lysate has demonstrated efficacy in promoting proliferation across different cell lines, including tumor cells and articular chondrocytes (
11), as well as in vivo expansion of various types of mesenchymal stromal cells (MSCs), endothelial colony-forming progenitor cells (ECFCs), and xeno-free propagation of human myoprogenitor cells (MPCs) (
17).